We invite you to participate in the non-commercial, multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial called ERICONS (Early RITUXIMAB in Childhood Onset Nephrotic Syndrome), which aims to evaluate the duration of disease remission in the treatment group compared to placebo.